Rag2Mol:基于提取增强生成的基于结构的药物设计
Peidong Zhang1,2, Xingang Peng3,4, Rong Han1,2
1Department of Computer Science and Technology, Tsinghua University, Haidian District, Beijing 100084, China.
Briefings in bioinformatics
|June 12, 2025
概括
人工智能 (AI) 通过设计适合3D口袋的分子来加速药物发现. 新的提取增强生成方法,Rag2Mol-G和Rag2Mol-R,产生优越的药物候选者,包括对于具有挑战性的目标,如PTPN2.
科学领域:
- 计算化学的计算化学
- 药用化学 医学化学
- 人工智能的人工智能
背景情况:
- 药物发现在识别具有最佳性质的化合物方面面临挑战.
- 基于结构的药物设计 (SBDD) 是有希望的,但受到数据偏差和缺乏合成可访问性的限制.
- 人工智能提供了进步,但当前的SBDD模型往往与实际的药物发现脱节.
研究的目的:
- 开发新的人工智能驱动的方法来设计适合特定3D蛋白质口袋的小分子.
- 解决现有SBDD模型的局限性,包括数据偏差和合成可访问性.
- 为具有挑战性的治疗目标确定强效药物候选者.
主要方法:
- 探索两个提取增强生成方法:Rag2Mol-G和Rag2Mol-R.
- Rag2Mol-G:生成分子,并在数据库中搜索可购买的类似化合物.
- Rag2Mol-R:通过从现有分子数据库中创建新的分子来生成分子,这些分子适合3D口袋.
主要成果:
- Rag2Mol 方法始终产生具有优异结合亲和度和药物相似度的候选药物.
- Rag2Mol-R显示了比先进的虚拟选模型更广泛的化学景观覆盖范围和更精确的准.
- 这两种工作流程都成功地确定了蛋白质氨酸酸酶PTPN2的有希望的抑制剂,这是以前无法使用的目标.
结论:
- 开发的Rag2Mol框架代表了人工智能驱动的SBDD的重大进步.
- 这些方法提供了一个高度可扩展的平台,用于整合各种SBDD方法.
- 这项工作推动了具有改进药物样性质和治疗潜力的小分子的设计.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
679
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
679
01:26Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
02:40Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K